Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.

Boschetti, Gilles

Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. [electronic resource] - Inflammatory bowel diseases Jan 2011 - 160-70 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1536-4844

10.1002/ibd.21308 doi


Adalimumab
Adult
Aged
Anti-Inflammatory Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Crohn Disease--drug therapy
Female
Flow Cytometry
Forkhead Transcription Factors--metabolism
Humans
Infliximab
Male
Middle Aged
Prognosis
Prospective Studies
T-Lymphocytes, Regulatory--immunology
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult